<DOC>
	<DOCNO>NCT00300378</DOCNO>
	<brief_summary>The primary objective compare antidepressant efficacy , safety , tolerability DVS SR versus placebo subject Major Depressive Disorder . Additional objective include test general functional quality-of-life outcome satisfaction therapy report subject .</brief_summary>
	<brief_title>Study Evaluating Efficacy Safety Desvenlafaxine Tablets Adult Outpatients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>A primary diagnosis MDD Depressive symptom least 30 day screen visit . Treatment DVS SR time past . Known hypersensitivity venlafaxine Significant risk suicide base clinical judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Depression</keyword>
	<keyword>Adult</keyword>
	<keyword>Outpatients</keyword>
</DOC>